Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in ZYME — Zymeworks Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$10,382,545
-$12,685,554 QoQ
Shares Held
397,190
-56.9% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ZYME ranks #41 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,382,545 397,190
2026-03-31 $23,068,099 921,250
2025-12-31 $42,018,281 1,595,833
2025-09-30 $26,386,855 1,544,898
2025-06-30 $19,386,774 1,544,763
2025-03-31 $18,491,606 1,552,612
2024-12-31 $22,644,741 1,546,772
2024-09-30 $19,187,983 1,528,923
2024-06-30 $20,068,188 2,358,189
2024-03-31 $9,354,909 889,250
2023-12-31 $9,232,917 888,635
2023-09-30 $728,167 114,853
2023-06-30 $5,228,356 605,134
2023-03-31 $5,275,119 583,531
2022-12-31 $5,623,357 715,440